All news AGC Biologics partners with Repair Biotechnologies to develop mRNA therapy for heart diseaseBy MichaelNovember 20, 2025 AGC Biologics has announced a collaboration with
All news Epirium Bio presents positive Phase 1 data for MF‑300 at GSA 2025By MichaelNovember 20, 2025 Epirium Bio, Inc.
All news Epirium Bio presents positive Phase 1 data for MF‑300 at GSA 2025By MichaelNovember 20, 2025 Epirium Bio, Inc.
All news Vasa Therapeutics secures FDA Fast Track status for VS‑041 in HFpEFBy MichaelNovember 20, 2025 Biotechnology firm Vasa Therapeutics announce
All news Vasa Therapeutics secures FDA Fast Track status for VS‑041 in HFpEFBy MichaelNovember 20, 2025 Biotechnology firm Vasa Therapeutics announce
All news Alzheon to showcase new clinical and neuroimaging results for ALZ‑801 at CTADBy MichaelNovember 20, 2025 Alzheon, Inc.
All news Alzheon to showcase new clinical and neuroimaging results for ALZ‑801 at CTADBy MichaelNovember 20, 2025 Alzheon, Inc.
All news EyePoint receives DSMC green light for pivotal Phase 3 DURAVYU trials in wet AMDBy MichaelNovember 20, 2025 EyePoint Pharmaceuticals announced that its indep
All news Oligomerix secures US$0.5 million NIH SBIR Fast-Track grant for Alzheimer’s tau therapeuticBy MichaelNovember 20, 2025 Biotechnology firm Oligomerix, Inc.
All news Mitophagy-promoting Parkinson’s drug funded into clinical trialsBy MichaelNovember 19, 2025 Vincere lands MJFF grant to support mitochondria
